Pasithea Therapeutics - Warrants (11/08/2026) OverviewPasithea Therapeutics - Warrants (11/08/2026) EBIT
EBIT (Earnings Before Interest and Taxes) analysis for KTTAW.
Quarterly EBIT
-$4.88B
↓ 32.51% YoY
As of Mar 31, 2026
Annual EBIT (TTM)
-$8.03B
↑ 24.45% YoY
Trailing 12 months ending Mar 31, 2026